Brian J. Lynch

2020 - Synta Pharmaceuticals

In 2020, Brian J. Lynch earned a total compensation of $4.4M as Senior Vice President and General Counsel at Synta Pharmaceuticals, a 9% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$260,946
Option Awards$3,749,840
Salary$425,417
Other$11,690
Total$4,447,893

Lynch received $3.7M in option awards, accounting for 84% of the total pay in 2020.

Lynch also received $260.9K in non-equity incentive plan, $425.4K in salary and $11.7K in other compensation.

Rankings

In 2020, Brian J. Lynch's compensation ranked 2,533rd out of 13,090 executives tracked by ExecPay. In other words, Lynch earned more than 80.6% of executives.

ClassificationRankingPercentile
All
2,533
out of 13,090
81st
Division
Manufacturing
969
out of 5,618
83rd
Major group
Chemicals And Allied Products
351
out of 2,251
84th
Industry group
Drugs
301
out of 1,951
85th
Industry
Pharmaceutical Preparations
219
out of 1,456
85th
Source: SEC filing on May 2, 2022.

Lynch's colleagues

We found four more compensation records of executives who worked with Brian J. Lynch at Synta Pharmaceuticals in 2020.

2020

Paul Friedman

Synta Pharmaceuticals

Chief Executive Officer

2020

Rebecca Taub

Synta Pharmaceuticals

Chief Medical Officer

2020

Remy Sukhija

Synta Pharmaceuticals

Senior Vice President, Chief Commercial Officer

2020

Marc Schneebaum

Synta Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like